Clinical Trials Browser

INDUSTRY × Diabetes Mellitus × Becaplermin × Clear all

NCT00518102 2016-07-19

The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])

Diabetes Mellitus, Neoplasms